Aldeyra Therapeutics Stock Price (NASDAQ:ALDX)

Add to My Stocks
$8.05 $0.2 (2.55%) ALDX stock closing price Sep 19, 2018 (Closing)
Prev Close* : $7.85
Market Cap:
$164.65M
Day Low: $7.95
52 Week Low: $5.55
Open: $7.95
Volume: -
Day High: $8.25
52 Week High: $9.30
Dividend:
0.00

Latest Stock Market News

Latest Articles

Aldeyra Therapeutics News - From Partners

ALDX Stockcharts

View ALDX PE ratio, PS ratio stocks charts and compare with peers.
ALDX Chart
Note: Compare Aldeyra Therapeutics stock price history with the index and industry peers.

Aldeyra Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Aldeyra Therapeutics Returns

ROE
(return on equity)

Aldeyra Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

ALDX Industry Peers

Company Price Change (%)
Tetraphase Pharmaceuticals (TTPH)3.010.11 (3.79%)
Nature's Sunshine Products (NATR)9.10.1 (1.11%)
Novartis (NVS)84.90.13 (0.15%)
Neous Therapeutics (NEOS)4.90.05 (1.01%)
Johnson & Johnson (JNJ)140.460.08 (0.06%)
Regeneron Pharma (REGN)383.74.63 (1.19%)
Applied Genetic Technologies (AGTC)4.350.1 (2.35%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Aldeyra Therapeutics Inc Stock News - Partner Headlines

Aldeyra Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-22.34M-18.69M-12.09M-5.18M13.06M
Total Operating Expense22.48M18.69M11.98M7.26M3.67M
View Aldeyra Therapeutics income statement
balance sheet20172016201520142013
Total Assets44.17M25.18M28.2M8.78M3.74M
Total Liabilities4.57M3.53M3.32M2.5M5.64M
Shareholders Equity39.6M21.64M24.87M6.28M-1.9M
View Aldeyra Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-----
Net Cash from (used by) Operating Activities-19.22M-15.14M-9.31M-4.77M-1.7M
Increase (Decrease) in Prop Plant And Equipment-0.02M-0.01M-0.08M-0.01M-
View Aldeyra Therapeutics cash flow statement

Aldeyra Therapeutics Stock Message Board

Aldeyra Therapeutics stock gained 2.55%, and the last close price as of Sep 19, 2018 is $8.05 for ALDX stock. The total market value as denoted by $164.65M for Aldeyra Therapeutics, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Aldeyra Therapeutics stock analysis.

The terms stocks and shares mean the same thing. For Ex: Aldeyra Therapeutics stock price and Aldeyra Therapeutics share price mean the same thing. 157,436 ALDX shares were traded yesterday, and Aldeyra Therapeutics stock chart shows that the ALDX stock quote hit a day high of $8.25 and day low of $7.95. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Aldeyra Therapeutics does not pay dividends. One can observe stock price trends and check for volatility by checking Aldeyra Therapeutics stock price history.